Showing results (361-370 of 2,330) with videos related to

Sort By:
Pageof 233
Clinical Drug Investigation|April 25, 2014
Clinical pharmacokinetics of the nicotinic channel modulator dexmecamylamine (TC-5214) in subjects with various degrees of renal impairmentSofie Alverlind, Stéphane Barassin, Per Dalén, et al.
Clinical Drug Investigation|September 27, 2014
Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective observational cohort study in Poland, Egypt, Mexico and ChinaXiaohua Hou, Shengliang Chen, Yali Zhang, et al.
Clinical Drug Investigation|September 13, 2014
Triple combination therapy in hypertension: the antihypertensive efficacy of treatment with perindopril, amlodipine, and indapamide SRDénes Páll, Ildikó Szántó, Zoltán Szabó
Clinical Drug Investigation|October 15, 2014
Levetiracetam pharmacokinetics in Japanese subjects with renal impairmentJunichi Yamamoto, Nathalie Toublanc, Yuji Kumagai, et al.
Clinical Drug Investigation|October 16, 2014
Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug productAnanya Sadhu, Prabhat Upadhyay, Aruna Agrawal, et al.
Clinical Drug Investigation|September 10, 2014
Initial 3-weeks' Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) followed by Clopidogrel alone in high-risk patients with Acute Non-Disabling Cerebrovascular Events (ADANCE): study protocol for a randomized controlled trialFang Yang, Hui Lei, Wenrui Jiang, et al.
Clinical Drug Investigation|July 25, 2013
Comparing pioglitazone to insulin with respect to cancer, cardiovascular and bone fracture endpoints, using propensity score weightsCarlos Vallarino, Alfonso Perez, Gregory Fusco, et al.
Clinical Drug Investigation|November 2, 2013
Comparison of algorithms for oral busulphan area under the concentration-time curve limited sampling estimateFredrik Sjöö, Ibrahim El-Serafi, Jon Enestig, et al.
Clinical Drug Investigation|November 2, 2013
Pharmacokinetics, safety and tolerability of rotigotine transdermal patch in healthy Japanese and Caucasian subjectsWilli Cawello, Seong R Kim, Marina Braun, et al.
Clinical Drug Investigation|August 27, 2013
Pharmacokinetic drug interactions involving vortioxetine (Lu AA21004), a multimodal antidepressantGrace Chen, Ronald Lee, Astrid-Maria Højer, et al.
Pageof 233